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Ectopic cardiac fatty images are not rarely detected incidentally by computed tomography and cardiac magnetic resonance, or by
exams focused on the heart as in general thoracic imaging evaluations. A correct interpretation of these findings is essential in order
to recognize their normal or pathological meaning, focusing on the eventually associated clinical implications.The development of
techniques such as computed tomography and cardiac magnetic resonance allowed a detailed detection and evaluation of adipose
tissue within the heart. This pictorial review illustrates the most common characteristics of cardiac fatty images by computed
tomography and cardiac magnetic resonance, in a spectrum of normal and pathological conditions ranging from physiological
adipose images to diseases presenting with cardiac fatty foci. Physiologic intramyocardial adipose tissue may normally be present
in healthy adults, being not related to cardiac affections and without any clinical consequence. However cardiac fatty images may
also be the expression of various diseases, comprehending arrhythmogenic right ventricular dysplasia, postmyocardial infarction
lipomatousmetaplasia, dilated cardiomyopathy, and lipomatous hypertrophy of the interatrial septum. Fatty neoplasms of the heart
as lipoma and liposarcoma are also described.
1. Introduction
Ectopic intracardiac fatty images are not uncommon findings
in thoracic imaging in both healthy and diseased patients.
Development of diagnostic techniques with high spatial
and contrast resolution as computed tomography (CT) and
cardiac magnetic resonance (CMR) enabled detailed fat
visualization within the heart. An incidental frequency of
cardiac adipose images in about 11% of the patients per-
forming cardiovascular CT examinations has been estimated
[1]. However foci of ectopic cardiac adipose tissue could
sometimes be not pointed out in radiological reports, even in
pathological conditions, mostly if the exam is not specifically
focused on the heart. This pictorial review has the aim of
illustratingCT andCMR features of cardiac fatty images, with
the purpose of assisting in recognizing their typical imaging
appearances. A selection of the most common characteristics
of cardiac fat in a spectrum of normal and pathological
conditions will be depicted, providing a simplified step-
by-step approach to discriminate between various imaging
patterns, outlined by the scheme in Figure 1. Different
imaging characteristics between physiologic and pathologic
intracardiac fat are summarized in Table 1, readapted from
Kimura et al. [2].
2. Nonpathological Ectopic Cardiac Fat
Physiologic ectopic cardiac adipose tissue may normally
be present in healthy adults not affected by any cardiac
disease, without clinical consequences [3]. In fact ectopic
intramyocardial fat extending from the epicardiac adipose
tissue is a relatively common incidental finding during a
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Table 1: Differentiating features between physiologic and pathologic cardiac fat.
Type of fat Patient’scharacteristics Cardiac location
Intramyocardial
distribution
Morphological
imaging pattern Myocardial thickness Ventricular size
Physiologic
Elderly, also
without any
cardiac disease
associated
More in the RV than
in LV: RV free wall,
RVOT, RV and LV
trabeculae, RV
moderator band,
interventricular
septum, RV apex
Mostly
subepicardial,
sometimes with
full thickness
Linear or patchy Normal or thickened Normal
ARVC
Young to middle
age, male
dominant
RV free wall, RVOT,
RV apex,
interventricular
septum, LV lateral
wall
Mostly
subepicardial Linear or patchy Thinned
Enlarged RV,
enlarged LV in
left-dominant
disease
PILM
Elderly or middle
age, generally male
dominant, within a
chronic MI
Usually in LV
myocardium, within a
chronic MI scar, in a
coronary artery
irroration territory
Mostly
subendocardial Linear
Thinned, sometimes
with calcifications
Normal or
enlarged LV
DCM Elderly or middleage
In LV myocardium,
following myocardial
fibrosis distribution
Mesocardial,
sparing the
subendo-
cardium, not in
a coronary
artery irroration
territory
Linear Thinned or normal Enlarged LV
LHIAS
Elderly or middle
age, female
dominant
Interatrial septum,
sparing the fossa
ovalis
Transmural in
the interatrial
septum
Lobular
Thickened interatrial
septum (usually
>2 cm in transverse
diameter)
Normal
ARVC: arrhythmogenic right ventricular cardiomyopathy; PILM: postmyocardial infarction lipomatous metaplasia; DCM: dilatative cardiomyopathy; LHIAS:
lipomatous hypertrophy of the interatrial septum; MI: myocardial infarction; RV: right ventricle; LV: left ventricle; RVOT: right ventricular outflow tract.Note.
Readapted from Kimura et al. [2].
routine chest or cardiac CT, usuallymore frequent in the right
ventricle (RV) than in the left ventricle (LV), with an overall
prevalence of RV ectopic intramyocardial fat of 16–43%, [3].
In a series of autopsies, RV cardiac adipose tissuewas detected
in 85% of patients free of cardiac diseases [4]. Especially
in the elderly, CT may commonly demonstrate physiologic
RV myocardial fat with linear or patchy morphology located
in the free wall, in the subepicardial layers of anterolateral
or apical segments, and in the RV outflow tract (RVOT),
together with a preserved myocardial thickness [5]. However
in some cases when RV fatty infiltration is more prominent
it can also extend from the epicardial region through the
myocardium until the subendocardial layer, with consequent
increase of the myocardial wall thickness [6]. Small amounts
of physiological fat can also be routinely detected in other
typical locations such as the RV and LV trabeculae, RV
moderator band, and interventricular septum as well as
in the LV apex (Figures 2 and 3). Frequency and degree
of RV ectopic intramyocardial fat increase with age, being
considered as a part of the aging process, while its relationship
with obesity remains still unclear [7]. When intracavitary
and circumscribed in morphology, nonpathological adipose
fatty foci may sometimes assume a pseudomass appearance,
resembling tiny cardiac tumors, as, for example, in the
adipose degeneration of the RV moderator band: in this
eventuality, knowledge of the most common locations of
physiologic cardiac fat and correlation with clinical data are
essential key points helping to orientate toward a correct
interpretation.
3. Arrhythmogenic Right
Ventricular Cardiomyopathy
Arrhythmogenic right ventricular cardiomyopathy (ARVC)
is an inherited cardiac disease characterized by structural and
functional abnormalities that may lead to arrhythmias and
sudden cardiac death [8]. Pathologic changes of this disease
are mostly represented in the RV, comprehending ventricular
dilatation, thinning of the free wall, microaneurysms, and
myocardial fibrofatty replacement phenomena [9]. Particu-
larly ectopic intramyocardial adipose tissue in ARVC consists
of a fibrolipomatous infiltrate that is usually placed along the
RV free wall in a prevalent subepicardial distribution [10].
Adipose myocardial infiltrationmay generally also take place
in the so-called triangle of dysplasia, a region comprehended
between the RV inflow tract, the RVOT, and the RV apex
[11]. Fibrofatty replacement in ARVC consists of a wave-front
phenomenon starting from the epicardium and extending
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Imaging features of cardiac adipose tissue at CT
Intracavitary IntramyocardialParacardiac/epicardial
Physiologic fat ARVC
Pseudomass True mass
PILM
Subendocardial Nonsubendocardial
CMR
Linear Nodular Lobular Patchy
Differential diagnoses
Nonischemic cardiomyopathies
Clinical correlation needed
Figure 1: Imaging features of cardiac adipose tissue by computed tomography. CT: computed tomography; ARVC: arrhythmogenic right
ventricular dysplasia; CMR: cardiac magnetic resonance; PILM: postmyocardial infarction lipomatous metaplasia.
(a) (b) (c)
(d) (e) (f)
Figure 2: Typical incidental physiologic cardiac fatty images detected by CT. (a) Small fatty foci are seen in right ventricular moderator
band (arrow) as within the interventricular septum (arrowhead) and in the left ventricular myocardial apex ((b) arrow). A small amount of
pericardial fluid is also noted in (a). (c) A linear shaped adipose infiltration is, respectively, illustrated in the right ventricular free wall (arrows)
as in the left ventricular apex (arrowhead), within the right ventricular moderator band ((d) arrow), in the right ventricular trabeculae ((e)
arrow), and at the right ventricular outflow tract ((f) arrow).
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Figure 3: Thoracic noncontrast CT axial image in a 45-year-old female without any cardiac disease incidentally reveals a curvilinear
hypodense stripe located within the subepicardial layer of the myocardium at the left ventricular apex, with negative attenuation values
(a). The finding is successively confirmed at a cardiac CT postcontrast medium administration in axial view ((b) arrow) and in short axis
multiplanar reconstruction ((c) arrow). In (d–f), the corresponding CMR exam, requested for a further evaluation, confirms the presence of
the hyperintense stripe at the same place on T1-weighted black blood in four chambers ((d) arrow) and in short axis view ((e) arrow), with
associated nulled signal on fat-suppressed T2-weighted image ((f) arrow), according to physiologic left ventricular apical fatty tissue.
to the endocardial layer, with the latter that is generally
spared (Figure 4). However there are histologic evidences
of fibrolipomatous metaplasia not only in the RV, but also
in the LV lateral wall in 47%–76% of cases and in the
interventricular septum in 20%, with a predilection for the
posterolateral and posteroseptal segments [7]. Notably LV
fatty involvement often occurs in the later stage of the disease
following the RV adipose infiltration, although some cases of
isolated LV disease have been previously reported (Figure 5)
[12]. However myocardial fibrofatty infiltration at imaging is
currently not included in the revised criteria for the diagnosis
of ARVC [13]. In fact, despite CMR being actually consid-
ered the more suitable noninvasive method for recogniz-
ing myocardial fatty replacement, differentiating myocardial
from epicardial fat may be challenging due to CMR limited
spatial and contrast resolution. In order to overcome this
issue, previous studies performed with CMR suggested the
use of Turbo Spin Echo T1-weighted black blood sequences
with and without fat saturation pulses to facilitate the differ-
entiation between pathological fatty infiltration from normal
epicardial adipose tissue [14]. Late gadolinium enhancement
(LGE) technique also demonstrated to be helpful in detecting
myocardial fibrous degeneration, although it may be difficult
to distinguish enhancement from intramyocardial fat located
in a thinned RV myocardium, because both appear with
hyperintense signal [15]. Furthermore CMR particularly rep-
resents the better technique to differentiate a fibrolipomatous
infiltration in ARVC fromphysiological fat, despite this being
not always straightforward because they both present with
linear or patchy morphology and spare the subendocardium:
however in ARVC fatty infiltration is usually present in a
RV free wall that is considerably thinned (generally <2mm),
while in nonpathological adipose myocardial infiltration the
wall thickness is normally preserved or even increased.
Finally other nonischemic cardiomyopathies should also be
included in the differential diagnosis with ARVC in presence
of adipose tissue not involving the subendocardial layer of
themyocardium: the correlationwith clinical data, the elderly
age, and the absence of the other CMR diagnostic criteria for
ARVC should more likely orientate to exclude this disease.
4. Postmyocardial Infarction
Lipomatous Metaplasia
Postmyocardial infarction lipomatous metaplasia (PILM) is
a tissue transformation process that may take place within
the scar region after a healed myocardial infarction (MI).The
prevalence of PILM at histology in the LV reached values
of 68–84% of excised heart transplanted for ischemic heart
disease [16]. In imaging studies the prevalence of PILM
among patients with history of LV MI ranged, respectively,
from 22%–62% with CT to 68% with CMR [17, 18]. PILM
correlates with elderly age, male gender, and conditions
related to reperfusion therapy as percutaneous coronary
artery intervention and placement of coronary artery by-pass
grafts [18]. This process is related to different factors as
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Figure 4: Arrhythmogenic right ventricular cardiomyopathy in a 27-year-old man presenting with palpitations. Cine-SSFP four-chamber
images, respectively, in diastole (a) and systole (b) demonstrate an aneurysmatic aspect with dyskinesia of the right ventricular free wall that
appears corrugated ((b) double-headed arrow). T1-weighted black blood sequences in short axis (c) and four-chamber (d) views demonstrate
adipose infiltration phenomena in the right ventricular free wall (arrows).
(a) (b) (c)
Figure 5: Biventricular arrhythmogenic ventricular cardiomyopathy in a 32-year-old man presenting with syncope and familiar history of
sudden cardiac death. Cardiac CT with multiplanar reconstruction in short axis plane (a) reveals right ventricular enlargement with diffuse
fatty infiltration of the right ventricular free wall (arrows). CMR exam in the same patient with T1-weighted black blood in four-chamber
plane (b) illustratesmultifocal adipose infiltration of the right ventricular free wall, of the right ventricular apex, andwithin the left ventricular
lateral wall (arrows). A four-chamber black blood T2-weighted image with fat suppression confirms the biventricular myocardial adipose
infiltration, with corresponding low intensity signal in the same locations (arrows).
the inability of necrotized myocytes to metabolize free
fatty acids, transdifferentiation of myocytes in adipocytes
after reperfusion therapy, and impaired regional myocardial
wall contractility [18]. Fatty myocardial metaplasia tends to
increase with time since MI, being usually seen in patients
presenting with a chronic MI, more than 6 months from
the acute ischemic event [19]. In fact it is known that
adipocytes are histologically preceded by fibrous scar tissue
onset; although it was noted that their presence begins early
after MI, they are not immediately detectable due to the
limited sensitivity of the current available imaging techniques
[19]. PILMgenerally does not present a transmural extension,
generally involving <75% of the myocardial thickness and
always originating from the subendocardial layer. A study
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Figure 6: Cardiac CT axial image without contrast media adminis-
tration in a 72-year-old male after an extensive chronic myocardial
infarction shows the presence of a curvilinear hypodense stripe
(arrows) with negative attenuation values (−20 Hounsfield units),
located within the subendocardial layer of the left ventricular apex
extending also to the left ventricular lateral wall, findings related to
a postischemic lipomatous metaplasia.
performed with CMR demonstrated that LV intramyocardial
fat volume in PILM is significantly related to parameters as
MI volume, LV ejection fraction, LV end-systolic, and end-
diastolic volume indexes [20]. The typical aspect of PILM in
CT consists of curvilinear hypodense stripes with negative
attenuation values (−20 Hounsfield units) located within
the subendocardial layer, often associated with myocardial
wall thinning and sometimes also with calcifications, con-
finated in a coronary artery perfusion territory (Figures
6 and 7). At CMR imaging PILM is generally detectable
as subendocardial hyperintense strikes both in T1-weighted
black blood and in T2-weighted bright blood sequences,
slightly less hyperintense in cine-SSFP imaging, with nulled
signal in fat suppression sequences. Furthermore PILM
is usually disposed within a thinned necrotic myocardial
wall that presents contraction abnormalities as dyskinesia
or hypokinesia. However despite an accurate evaluation at
CMR, it may be challenging to clearly differentiate PILM
located in the RV from a physiologic fat infiltration only
on the base of the current imaging findings, due to the
normally thinner aspect of the RV free wall. Recently CMR
with T1-mapping technique by Sh-MOLLI sequences have
been proposed to detect PILM in patients with chronic
MI, reporting increased native-T1 values in the infarcted
region compared to remote myocardium, maybe related to
the presence of fat [21]. Although it is not clear how these
findings could have been affected by PILM, this suggests
that T1-mapping technique may have the potential to detect
small foci of intramyocardial fat even in an early stage after
MI.
5. Dilated Cardiomyopathy
Idiopathic or “primary” dilated cardiomyopathy (DCM) is
characterized by left or biventricular dilatation and impaired
systolic function without significant coronary artery lesions,
excluding other possible etiologic causes [22]. Primary forms
represent about 30–40%of cases, while secondary subtypes of
DCMderive fromaheterogeneous group of affections includ-
ing ischemic, inflammatory, autoimmune, toxic, ormetabolic
disorders [22]. Specific hallmarks of DCM at histology
include hypertrophy and degeneration of the myocytes,
interstitial fibrosis, intramyocardial cluster of lymphocytes,
and finally fibrofatty infiltration [23]. Intramyocardial fat
deposition is a relatively common phenomenon in DCM,
resulting in about 18–24% of cases [24]. The pathogenesis of
fatty metaplasia in DCM is still unknown, but intramyocar-
dial fibrosis could probably be the precursor of adipose tissue,
such as mentioned above in PILM. However in primary
DCM this process may be rather histologically related to the
apoptotic phenomena ofmyocardialmyocytes and interstitial
cells, with a prevalence of lipomatous metaplasia reported
until 26% of myocardial fibrosis areas from an autopsy study
[25]. CMR has the capability to detect both myocardial
fibrosis and intramyocardial fatty deposition: notably in
DCM the typical location of adipose tissue usually follows
myocardial fibrosis, being represented by curvilinear fatty
stripes with mesocardial distribution detectable within the
LV myocardium (Figure 8). Furthermore a study involving
85 DCM patients reported a prevalence of concomitant
fat deposition and enhancement of 8% of the patients,
enhancement without accompanying fat of 18%, and sole fat
deposit without enhancement of 1%: these data strengthen
the association between combined fibrosis and adipose tis-
sue metaplasia [26]. However distinguishing fibrous tissue
from fat in LGE sequences may be difficult even at CMR,
because both present with high signal. Lu et al. proposed
a fat-water separation imaging in DCM to distinguish fat
from fibrosis at LGE imaging, moreover pointing out that
intramyocardial fat volume was significantly related to LV
global function [27]. These findings may suggest that adi-
pose deposition in DCM could be an indicator of a worse
prognosis.
Regarding the differential diagnoses of this disease, left-
dominant ARVC with fibrofatty replacement of the LV
represents an affection hardly distinguishable from idiopathic
DCM at CMR imaging: in this case a careful evaluation of the
adipose tissue and of the LGE location is crucial, being both
in ARVC predominantly represented in the subepicardium
and not in the middle layer of the myocardium as in primary
DCM.
Besides the evidence of fatty intramyocardial tissue at
imaging sparing the subendocardial layer and having no
relationship with a coronary artery perfusion territory allows
excluding a DCM secondary to a PILM.
Finally fatty myocardial metaplasia phenomena in sec-
ondary DCM have also been described after an inflam-
matory process as chronic myocarditis (Figure 9) [28].
In these patients ventricular dilatation may occur in the
late stage after inflammation as a consequence of a direct
damage of the myocytes by the etiologic agent causing
extensive myocardial injury [29]. This process may lead
to a DCM pattern of presentation with associated adipose
metaplasia of the damagedmyocytes, probably hypothesizing
the same histological mechanisms previously described in
PILM.
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Figure 7: Cardiac CT after contrast medium administration in three different patients with postinfarction lipomatous metaplasia. (a)
demonstrates a curvilinear hypodense fatty stripe with subendocardial distribution located in the anterior segment of the left ventricular
myocardium in a short axis multiplanar reconstruction (red arrows). A similar finding is present in axial view (b) in the interventricular
septum and left ventricular apex, also associated with tiny calcifications and wall thinning (red arrows). In (c) a lipomatous metaplasia
involving the whole interventricular septum together with remarkable corresponding wall thinning is illustrated on a short axis multiplanar
reconstruction (red arrows).
(a) (b) (c)
Figure 8: CMR examination in a 62-year-old woman with idiopathic dilatative cardiomyopathy. Four-chamber T1-weighted black blood
image (a) demonstrates left ventricular chamber enlargement with an intramyocardial hyperintense stripe in the interventricular septum.
Short axis black blood T2-weighted with fat suppression (b) shows a signal drop of the stripe, confirming the presence of intramyocardial fat.
On short axis late gadolinium enhancement T1-weighted sequence (c) the adipose tissue location corresponds to myocardial enhancement
due to concomitant intramyocardial fibrosis with mesocardial distribution within the interventricular septum.
6. Lipomatous Hypertrophy of
the Interatrial Septum
Lipomatous hypertrophy of the interatrial septum (LHIAS)
is an uncommon benign disorder with fatty accumulation
into the interatrial septum that usually measures a transverse
diameter > 2 cm in this condition [30]. LHIAS is histo-
logically characterized by adipocytes hyperplasia with fat
infiltration between the myocardial fibers of the interatrial
septum [31]. The overall prevalence of this condition in the
general population is estimated to be about 1–8%, being
more frequent in the elderly and obesity, with a higher
incidence reported in women [32]. LHIAS is asymptomatic
in the majority of cases, but it may also be related to
supraventricular cardiac arrhythmias, P-wave alterations on
electrocardiogram, pericardial effusions, and sudden cardiac
death [32]. Being mostly asymptomatic, this condition is
generally diagnosed incidentally at imaging, surgery, or
autopsy [32]. Its usual imaging appearance in CT or CMR
is characteristic, consisting of a typical smooth dumbbell-
shaped fatty mass with lobular pattern of presentation,
located within the interatrial septum (Figures 10 and 11).
Notably LHIAS typically spares the fossa ovalis and does not
show contrast enhancement.
7. Other Diseases
Tuberous sclerosis complex (TSC) represents a genetic mul-
tisystemic disorder with cardiac tumor-like manifestations
such as rhabdomyomas that regress during childhood and
intramyocardial fat-containing lesions in adults [33]. Fatty
images within the heart in TSC are often incidentally
described during chest CT requested to evaluate pulmonary
lymphangioleiomyomatosis, a lung disease associated with
TSC [34]. A previous study found an incidence of fatty
intramyocardial foci of 64% in a group of 55 TSC patients
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Figure 9: Postinflammatory lipomatous metaplasia in a 52-year-old man at 6 months from an acute viral lymphocytic myocarditis. Cardiac
CT in axial view (a) illustrates linear hypoattenuating stripes with negative attenuation values placed in the subepicardial layer of the left
ventricular myocardium, involving the apex (arrow) and the lateral wall (arrowhead). The lateral wall fatty involvement is evident also in
short axis multiplanar reconstruction ((b) arrows). A mild enlargement of left ventricle is also noted (a). CMR in the same patient with late
gadolinium enhancement T1-weighted sequences, respectively, in four-chamber (a) and short axis (d) planes shows a patchy and curvilinear
enhancement in the interventricular septum (arrows), left ventricular apex, and lateral wall (arrowheads), sparing the subendocardial layer
and not following a coronary artery perfusion territory, findings compatible with a postinflammatory damage.
evaluated by CT [35]. Although multiple intramyocardial
lipomas (LP) have been associated with TSC, it remains
uncertain if fatty foci actually represent true LP [35]. A
possible relationship between the presence of renal angiomy-
olipomas and cardiac fat-containing lesions in TSC has
also been hypothesized, considering fat lesions as cardiac
localizations of angiomyolipomas [36]. Notwithstanding the
natural history of these fatty foci and their potential clinical
implications are still not clear, their presence currently being
not included in the established diagnostic criteria for TSC
[37]. However in patients presenting with multiple focal
intramyocardial fat depositions detected at imaging, possible
manifestations of TSC in other organs should be investigated.
In this disease both CT and CMR usually demonstrate
circumscribed fatty foci or present with a patchy appearance,
mainly located in the interventricular septum and in the
LV lateral wall (Figure 12). Notably adipose lesions in TSC
generally do not show an invasive behaviour or contrast
enhancement, even when large in dimensions [38].
Muscular dystrophies (MD) are X-linked recessive dis-
eases characterized by cardiac involvement with replacement
of the myocardium by connective and adipose tissue [39].
Particularly in Duchenne and Becker muscular dystrophies
the myocardial regions most extensively affected are the
LV inferobasal and later wall, with sparing of the RV and
the atria [40]. Typical manifestations of MD consist of
LV dysfunction and heart failure, although the presence of
ectopic intramyocardial fat in MD has never been reported
with current imaging techniques, being revealed only by
histology [40].
Hypertrophic cardiomyopathy (HCM) has also been
described to be related to the presence of intramyocardial
fatty foci, with adipose tissue placed within the thickened
myocardial segments involved by this disease [41]. The
real incidence and underlying causes of fatty myocardial
metaplasia in HCM are actually unknown; however ectopic
intramyocardial fatty foci in patients with a thickened LVwall
reported an incidence of 11% performing thoracic CT [9].
Although the presence of ectopic adipose tissue within
the myocardium is often detectable in CT and CMR images,
the “cardiac steatosis” defined as cardiomyocytes accumu-
lation of lipids is not easily appreciable with these imaging
techniques. Cardiomyopathies secondary to lipidmetabolism
disorders may have a heterogeneous clinical expression,
mimic dilated or hypertrophic cardiomyopathy, and led to
progressive heart failure.
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Figure 10: Lipomatous hypertrophy of the interatrial septum as incidental finding in an asymptomatic 72-year-old female. CT imaging
of the heart in precontrast scan (a) and after contrast medium administration (b) in axial views demonstrates a bilobular dumbbell shape
hypoattenuating lesion with lobular morphology located within the interatrial septum that appears thickened (arrows). CMR examination
requested for a further evaluation confirms the presence of a bilobular mass with corresponding hyperintensity in four-chamber cine-SSFP
sequence surrounded by the typical black boundary artefact ((c) arrows) as in T1-weighted black blood image ((d) arrows), with low signal
on black blood T2-weighted sequence with fat suppression (arrows).
∗
(a)
∗
(b)
Figure 11: CMR exam in a lipomatous hypertrophy of the interatrial septum in an asymptomatic 68-year-old female. Four-chamber black
blood T1-weighted image (a) shows a hyperintense lobular mass infiltrating the interatrial septum and part of the posterior wall of the right
atrium (asterisk). Corresponding T1-weighted image with fat suppression (b) demonstrates homogeneous signal drop of themass, confirming
the presence of adipose tissue (asterisk).
Fabry disease is a rare X-linked genetic lysosomal storage
disease, resulting from dysfunctional metabolism of sphin-
golipids [42].
Intramyocardial triglyceride deposition is linked to var-
ious pathological hereditary and acquired conditions (e.g.,
diabetes mellitus, metabolic syndrome, and obesity).
Triglyceride deposit cardiomyovasculopathy is a genetic
disorder with accumulation of triglyceride in cardiomyocytes
and smooth muscle cells due to abnormal intracellular
deposit of triglyceride and its substrates [43, 44].
Usually in these conditions myocardial signal is not
altered in the conventional T1- and T2-weighed sequences,
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Figure 12: Axial thoracic noncontrast CT scan (a) shows multiple biventricular cardiac fatty foci with patchy pattern of appearance (arrows)
in a patient with TSC, findings noted during an exam requested to evaluate pulmonary lymphangioleiomyomatosis. CMR with T1-weighted
black blood four-chamber image (b) in the same patient confirms the presence of multiple corresponding fatty areas within the myocardium
showing hyperintense signal (arrows).
whereas T1 mapping technique has emerged as a sensitive
and specific CMR biomarker of tissue lipid accumulation
irrespective of ventricular morphology and function [45].
Moreover a case has been reported where the excessive
production of fatty acids in subjects with high alcohol con-
sumption caused an alcohol-related cardiomyopathy associ-
ated with left ventricular fatty infiltration [46].
8. Lipoma
LP represent the secondmost common benign cardiac tumor
after myxomas, accounting for about 10% of primary cardiac
neoplasms [47]. They are often discovered incidentally but in
rare cases they can become symptomatic due to obstruction
of blood flow or compression of the ventricular chambers.
The majority of LP are in extramyocardial location although
they can also be intramyocardial, arising in any cardiac
chamber and within the pericardial space, at any age [48].
These tumors are generally slow growing but, depending
on their location, may, respectively, rarely cause compres-
sion of the coronary arteries or of the pericardial space
when placed in the subepicardial layer, outflow obstruction
when located in the subendocardium, or arrhythmias when
intramyocardial [49]. Most are solitary tumors occupying
the right atrium or the LV chamber, but multiple cardiac
LP can also occur and have been described in patients with
TSC, although it is not currently established if fat lesions
in TSC histologically represent true LP [50]. In CT imaging
LP are fat attenuating, well-circumscribed, and encapsulated
masses showing a nodular pattern of appearance, without
contrast enhancement. At CMR examination LP generally
show a homogeneous nodular high signal intensity on T1-
weighted images, slightly less hyperintensity on T2-weighted
sequences, and suppression on fat-saturated images, similar
to subcutaneous or mediastinal fat (Figure 13). When LP are
intramyocardial they are usually seen on cine-SSFP image
as high-signal-intensity nodular areas surrounded by a black
boundary artefact, normally present at muscle-fat interface
[51]. Sometimes internal thin septations could be noted, while
they are not enhanced after contrast material administration.
Differentiation between LP and LHIAS is generally not so
difficult, with the lattermanifesting as an adipose unencapsu-
lated bilobularmass located in the interatrial septum showing
a characteristic lobular dumbbell shape, sparing the fossa
ovalis.
9. Liposarcoma
Primary cardiac liposarcomas (LS) are extremely rare neo-
plasms, mostly originating from the right chambers of the
heart, particularly from the right atrium [52]. Cardiac LS
usually remain undiagnosed until symptoms of infiltration of
the surrounding anatomical structures develop, such as chest
pain and dyspnea or signs of congestive heart failure in the
late stage [53]. The most common histological subtype of LS
is the well-differentiated subtype (or “lipoma-like” due to a
higher amount of fat content: 40–50% of cases), but they can
also present as myxoid, round-cell, or pleomorphic [54]. The
well-differentiated and the myxoid subtypes generally show
local aggressive behaviour, while the latter two subtypes early
metastasize to the lungs and frequently recur locally after
surgical resection [55].
Cardiac metastases from a primary LS located in other
anatomical districts have also been reported, although rare
[56]. In fact LS represents the second most common tumor
producing cardiac metastases after malignant histiocytoma
among soft-tissue neoplasms, with about 10–18% of all cases
[57]. Particularly myxoid variant LS constitutes the most
frequent histological subtype with metastatic potential to the
heart (about 30–50% of cases) [57].
Typical features in CT imaging of cardiac primary LS
or its metastatic lesions consist of large unencapsulated
hypoattenuating inhomogeneous masses, mostly rounded
shaped with thick septa and mild contrast enhancement,
infiltrating the surrounding cardiac structures and the peri-
cardium (Figure 14). Notably LS may have different patterns
of attenuation in CT depending on the amount of fat and
combined soft-tissue components within the tumor. CMR
is able to better define the infiltration of the surrounding
structures and allows evaluating possible functional damage
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Figure 13: Interventricular septal lipoma incidentally detected in a 79-year-old male with concomitant left renal cancer on a staging total
body CT exam ((a) asterisk). During thoracic CT scan a hypoattenuating nodular-shaped lesion with negative attenuation values located in
the interventricular septum is incidentally noted before ((b) arrow) and after contrast medium administration ((c) arrow). A renal cancer
metastatic lesion in the lateral wall of the left ventricle ((c) asterisk) is also present, together with moderate pericardial fluid. CMR in four-
chamber views in the bottom line images confirms the nodular area placed within the interventricular septum on cine-SSFP sequences that
appears hyperintense and delimited by the characteristic black boundary artefact ((d) arrow), with hyperintense signal also on T1-weighted
black blood sequence ((e) arrow) and hypointense appearance on T2-weighted black blood with fat suppression ((f) arrow). These findings
are related to an interventricular septal lipoma ((b)–(f) arrow) with a concomitant left ventricular renal cancer metastatic lesion ((c)–(f)
asterisk), both histologically proven.
∗
Figure 14: Histologically proven cardiac primarywell-differentiated
liposarcoma incidentally detected on a CT scan in a 73-year-old
patient presenting with chest pain and dyspnea. The noncontrast
CT axial image shows a hypoattenuating solid mass (asterisk) with
prevalent negative densitometric values, inhomogeneous content,
and irregularmargins, extending from the right atrium into the right
ventricle through the tricuspid valve, as for an infiltrative behaviour.
A mild amount of pericardial fluid is also noted.
on vascular and valvular components of the heart. In terms
of differential diagnosis, it could sometimes be difficult to
distinguish well-differentiated LS from LP based only on
the current imaging techniques, since moreover both have
a nodular pattern of appearance. However LS, unlike LP,
are usually unencapsulated and have infiltrative behaviour
and contrast enhancement. Other findings more orientat-
ing toward LS comprehend an inhomogeneous appearance
despite the presence of an intralesional fatty portion, larger
dimensions, and a more prominent soft-tissue component.
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